Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Nocardia infections
MeSH D009617 - nocardia infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D000193:
Actinomycetales infections
42 Companies
4 Drugs
$
Success rate
D009617:
Nocardia infections
44 Companies
6 Drugs
$
Success rate
D008271:
Mycetoma
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
100
%
3/3
Approved:
3
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Roche
Sulfamethoxazole
Eli Lilly
Sulfadiazine
,
Sulfadiazine, silver
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use